Login with your work email address to view charts. No credit card required.
| Art Unit: | 1635 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 536 — Organic compounds -- part of the class 532-570 series 424 — Drug, bio-affecting and body treating compositions 506 — Combinatorial chemistry technology: method, library, apparatus 800 — Multicellular living organisms and unmodified parts thereof and related processes 504 — Plant protecting and regulating compositions 976 — Nuclear technology |
| Phone: | (571) 272-8008 |
| Email: | dana.shin@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Biolgy |
| Service: | 20 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 23% over 485 cases |
|---|---|
| Difficulty: | Extremely Hard |
| Difficulty Percentile: | 93rd
|
With Examiner Shin, you have a 23% chance of getting an issued patent by 3 years after the first office action. Examiner Shin is an extremely hard examiner and in the 93rd percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Shin, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Shin's grant rate is lower than that of Art Unit 1635 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Shin | 2.6 |
| Art Unit 1635 | 1.6 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.